Loading…
In Vivo Cardiac Electrophysiologic Effects of a Novel Diphenylphosphine Oxide IKur Blocker, (2-Isopropyl-5-methylcyclohexyl) Diphenylphosphine Oxide, in Rat and Nonhuman Primate
The voltage-gated potassium channel, Kv1.5, which underlies the ultrarapid delayed rectifier current, I Kur , is reported to be enriched in human atrium versus ventricle, and has been proposed as a target for novel atrial antiarrhythmic therapy. The administration of the novel I Kur blocker (2-isopr...
Saved in:
Published in: | The Journal of pharmacology and experimental therapeutics 2006-02, Vol.316 (2), p.727-732 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The voltage-gated potassium channel, Kv1.5, which underlies the ultrarapid delayed rectifier current, I Kur , is reported to be enriched in human atrium versus ventricle, and has been proposed as a target for novel atrial antiarrhythmic
therapy. The administration of the novel I Kur blocker (2-isopropyl-5-methyl-cyclohexyl) diphenylphosphine oxide (DPO-1) (0.06, 0.2, and 0.6 mg/kg/min i.v. Ã 20 min; total
doses 1.2, 4.0, and 12.0 mg/kg, respectively) to rat, which exhibits I Kur in both atria and ventricle, elicited significant, dose-dependent increases in atrial and ventricular refractory period (9-42%)
at all doses tested, with no changes in cardiac rate or indices of cardiac conduction. Plasma levels achieved in rat at the
end of the three infusions were 1.1, 4.1, and 7.7 μM. Reverse transcription-polymerase chain reaction analysis of African
green monkey atria and ventricle demonstrated an atrial preferential distribution of Kv1.5 transcript. The administration
of DPO-1 (1.0, 3.0, and 10.0 mg/kg i.v.; 5-min infusions) to African green monkey elicited significant increases in atrial
refractoriness (approximately 15% increase at the 10.0 mg/kg dose), with no change in ventricular refractory period, ECG intervals,
heart rate, or blood pressure. Plasma levels of DPO-1 achieved in African green monkey were 0.58, 1.12, and 5.43 μM. The concordance
of effect of DPO-1 on myocardial refractoriness with distribution of Kv1.5 in these two species is consistent with the I Kur selectivity of DPO-1 in vivo. Moreover, the selective increase in atrial refractoriness in primate supports the concept of
I Kur blockade as an approach for the development of atrial-specific antiarrhythmic agents. |
---|---|
ISSN: | 0022-3565 1521-0103 |
DOI: | 10.1124/jpet.105.094839 |